Trial Details
RECRUITINGBasic Information
| Clinical ID | c952 |
|---|---|
| Identifier | NCT06459297 |
| Trial Title | Study of Oral Upadacitinib to Assess Change in Disease Activity and Adverse Events in Adult Participants With Ulcerative Colitis or Crohn's Disease |
| Trial URL | Visit Original Page |
Study Information
| Study Results | NO |
|---|---|
| Conditions | Ulcerative Colitis|Crohn's Disease |
| Interventions | - |
Participant Information
| Sponsor | AbbVie |
|---|---|
| City | Cheonan-si |
| Country/Region | Korea, Republic of |
Enrollment Criteria
| Sex Requirement | ALL |
|---|---|
| Age Requirement | ADULT, OLDER_ADULT |
Study Design
| Study Type | OBSERVATIONAL |
|---|---|
| Phase | - |
Time Information
| Start Date | 2024-06-24 |
|---|---|
| Primary Completion Date | 2025-12-25 |
| Completion Date | 2025-12-25 |